Baicalin Prevents Colon Cancer by Suppressing CDKN2A Protein Expression.

Objective: To observe the therapeutic effects and underlying mechanism of baicalin against colon cancer.

Methods: The effects of baicalin on the proliferation and growth of colon cancer cells MC38 and CT26. WT were observed and predicted potential molecular targets of baicalin for colon cancer therapy were studied by network pharmacology.